Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

The rabies virus interferon antagonist P protein interacts with activated STAT3 and inhibits Gp130 receptor signaling.

Lieu KG, Brice A, Wiltzer L, Hirst B, Jans DA, Blondel D, Moseley GW.

J Virol. 2013 Jul;87(14):8261-5. doi: 10.1128/JVI.00989-13. Epub 2013 May 22.

2.

Interaction of rabies virus P-protein with STAT proteins is critical to lethal rabies disease.

Wiltzer L, Okada K, Yamaoka S, Larrous F, Kuusisto HV, Sugiyama M, Blondel D, Bourhy H, Jans DA, Ito N, Moseley GW.

J Infect Dis. 2014 Jun 1;209(11):1744-53. doi: 10.1093/infdis/jit829. Epub 2013 Dec 23.

PMID:
24367042
4.
5.
6.

The importance of being short: the role of rabies virus phosphoprotein isoforms assessed by differential IRES translation initiation.

Marschalek A, Drechsel L, Conzelmann KK.

Eur J Cell Biol. 2012 Jan;91(1):17-23. doi: 10.1016/j.ejcb.2011.01.009. Epub 2011 Mar 12.

PMID:
21397980
7.
8.

Interferon in rabies virus infection.

Rieder M, Conzelmann KK.

Adv Virus Res. 2011;79:91-114. doi: 10.1016/B978-0-12-387040-7.00006-8. Review.

PMID:
21601044
9.

STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes.

Krejci P, Salazar L, Goodridge HS, Kashiwada TA, Schibler MJ, Jelinkova P, Thompson LM, Wilcox WR.

J Cell Sci. 2008 Feb 1;121(Pt 3):272-81. doi: 10.1242/jcs.017160. Epub 2008 Jan 15.

10.

Double-labeled rabies virus: live tracking of enveloped virus transport.

Klingen Y, Conzelmann KK, Finke S.

J Virol. 2008 Jan;82(1):237-45. Epub 2007 Oct 10.

11.

Genetic dissection of interferon-antagonistic functions of rabies virus phosphoprotein: inhibition of interferon regulatory factor 3 activation is important for pathogenicity.

Rieder M, Brzózka K, Pfaller CK, Cox JH, Stitz L, Conzelmann KK.

J Virol. 2011 Jan;85(2):842-52. doi: 10.1128/JVI.01427-10. Epub 2010 Nov 17. Erratum in: J Virol. 2012 Apr;86(8):4720.

12.

Ups and downs: the STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling.

Regis G, Pensa S, Boselli D, Novelli F, Poli V.

Semin Cell Dev Biol. 2008 Aug;19(4):351-9. doi: 10.1016/j.semcdb.2008.06.004. Epub 2008 Jun 22. Review.

PMID:
18620071
13.

Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling.

Jenkins BJ, Grail D, Nheu T, Najdovska M, Wang B, Waring P, Inglese M, McLoughlin RM, Jones SA, Topley N, Baumann H, Judd LM, Giraud AS, Boussioutas A, Zhu HJ, Ernst M.

Nat Med. 2005 Aug;11(8):845-52. Epub 2005 Jul 24.

PMID:
16041381
14.

Role of interferon antagonist activity of rabies virus phosphoprotein in viral pathogenicity.

Ito N, Moseley GW, Blondel D, Shimizu K, Rowe CL, Ito Y, Masatani T, Nakagawa K, Jans DA, Sugiyama M.

J Virol. 2010 Jul;84(13):6699-710. doi: 10.1128/JVI.00011-10. Epub 2010 Apr 28.

15.

Deregulated Stat3 signaling dissociates pulmonary inflammation from emphysema in gp130 mutant mice.

Ruwanpura SM, McLeod L, Miller A, Jones J, Vlahos R, Ramm G, Longano A, Bardin PG, Bozinovski S, Anderson GP, Jenkins BJ.

Am J Physiol Lung Cell Mol Physiol. 2012 Apr 1;302(7):L627-39. doi: 10.1152/ajplung.00285.2011. Epub 2012 Jan 20.

16.

Functional involvement of Daxx in gp130-mediated cell growth and survival in BaF3 cells.

Muromoto R, Kuroda M, Togi S, Sekine Y, Nanbo A, Shimoda K, Oritani K, Matsuda T.

Eur J Immunol. 2010 Dec;40(12):3570-80. doi: 10.1002/eji.201040688. Epub 2010 Nov 11.

18.

Mammary gland remodeling depends on gp130 signaling through Stat3 and MAPK.

Zhao L, Hart S, Cheng J, Melenhorst JJ, Bierie B, Ernst M, Stewart C, Schaper F, Heinrich PC, Ullrich A, Robinson GW, Hennighausen L.

J Biol Chem. 2004 Oct 15;279(42):44093-100. Epub 2004 Jul 30.

19.

STAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7-sensitive kinase.

Boulton TG, Zhong Z, Wen Z, Darnell JE Jr, Stahl N, Yancopoulos GD.

Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):6915-9.

20.

Wild-type rabies virus phosphoprotein is associated with viral sensitivity to type I interferon treatment.

Niu X, Tang L, Tseggai T, Guo Y, Fu ZF.

Arch Virol. 2013 Nov;158(11):2297-305. doi: 10.1007/s00705-013-1743-2. Epub 2013 Jun 7.

PMID:
23744308

Supplemental Content

Support Center